Related Experiment Video
Updated: Mar 3, 2026

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
Roles of platelet-derived growth factor in vascular calcification
Liu Ouyang1,2, Kun Zhang1,2, Jie Chen2,3
1Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Department of Cardiology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
Insights
Vascular calcification (VC) is a complex process accelerated by platelet-derived growth factor (PDGF). Understanding PDGF
Area of Science:
- Cardiovascular Biology
- Vascular Biology
- Biomedical Research
Background:
- Vascular calcification (VC) is common in aging, hypertension, chronic kidney disease (CKD), and diabetes.
- VC is an active process involving complex mechanisms of calcium deposition in blood vessels.
- Current therapies for VC are limited due to its complicated pathogenesis.
Purpose of the Study:
- To review the role of platelet-derived growth factor (PDGF) in vascular calcification.
- To identify PDGF as a potential therapeutic target for VC.
Main Methods:
- Literature review focusing on PDGF's involvement in VC.
- Analysis of mechanisms by which PDGF influences vascular homeostasis.
Main Results:
- PDGF acts as a mitogen and chemoattractant, disrupting vascular homeostasis.
- PDGF contributes to VC by inducing inflammation, oxidative stress, and phenotype transition.
Conclusions:
- PDGF plays a significant role in accelerating vascular calcification.
- Targeting PDGF may offer a novel therapeutic strategy for treating VC.
Abstract:
Vascular calcification (VC) is prevalent in aging, and patients with hypertension, chronic kidney disease (CKD), or diabetes. VC is regarded as an active and complex process that involves multiple mechanisms responsible for calcium deposition in vessel wall. In light of the complicated pathogenesis of VC, effective therapy for ameliorating VC is limited. Thus, it is urgent to explore the potential mechanisms and find new targets for the therapy of VC. Platelet-derived growth factor (PDGF), a potent mitogen, and chemoattractant have been found to disturb the vascular homeostasis by inducing inflammation, oxidative stress, and phenotype transition, all of which accelerate the process of VC. The aim of current review is to present a review about the roles of PDGF in affecting VC and to establish a potential target for treating VC.
More Related Videos
09:34Visualizing Angiogenesis by Multiphoton Microscopy In Vivo in Genetically Modified 3D-PLGA/nHAp Scaffold for Calvarial Critical Bone Defect Repair
Published on: September 7, 2017
09:01Analysis of Extracellular Vesicle-Mediated Vascular Calcification Using In Vitro and In Vivo Models
Published on: January 27, 2023
Related Concept Videos
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Roles of Electrolytes: Calcium and Phosphate
The calcium concentration in blood plasma is primarily...
Clot Retraction and Fibrinolysis
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Regulation of Angiogenesis and Blood Supply